New York Blood Center Unveils NYBC Ventures.
NEW YORK, New York
Blood Centers of America member, New York Blood Center, unveils its $50 million investment fund called NYBC Ventures. This newly formed investment fund focusses on blood and cellular therapeutics.
The financing for this new venture is tied to proceeds from solvent detergent plasma processes, patented by NYBC. Since 2021, these funds have been used toward new startups such as Thymmune Therapeutics and STRM.BIO.